We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDR
6151
DELISTED
Cedar Realty Trust, Inc
CDR
– –
-40
Closed -$1K
LEAP
6152
DELISTED
Ribbit LEAP, Ltd.
LEAP
– –
-1,186
Closed -$13K
LNFA.U
6153
DELISTED
L&F Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one rede
LNFA.U
– –
-66
Closed -$1K
SOLN
6154
DELISTED
The Southern Company
SOLN
– –
-1,328
Closed -$68K
ETTX
6155
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
– –
-13,918
Closed -$30K
LBPS
6156
DELISTED
4D Pharma PLC
LBPS
– –
-8
Closed –
SRRA
6157
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-388
Closed -$7K
ELMSW
6158
DELISTED
Electric Last Mile Solutions, Inc. Warrant
ELMSW
$0 ﹤0.01%
+83
New +$144
RENO
6159
DELISTED
Renovare Environmental, Inc. Common Stock
RENO
– –
-267
Closed –
OACB
6160
DELISTED
Oaktree Acquisition Corp. II
OACB
– –
-347
Closed -$3K
PBLA
6161
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
– –
0
– -$3K
TCAC
6162
DELISTED
Tuatara Capital Acquisition Corporation Class A Ordinary Shares
TCAC
$0 ﹤0.01%
+33
New +$321
STRDW
6163
DELISTED
Sitio Royalties Corp. Warrant
STRDW
$0 ﹤0.01%
248
– –
POTX
6164
DELISTED
Global X Cannabis ETF
POTX
– –
-290
Closed -$28K
TACA
6165
DELISTED
Trepont Acquisition Corp I
TACA
– –
-659
Closed -$6K
CAS
6166
DELISTED
Cascade Acquisition Corp.
CAS
$0 ﹤0.01%
+24
New +$238
HSTO
6167
DELISTED
Histogen Inc. Common Stock
HSTO
– –
-5
Closed –
CMPI
6168
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
– –
-1,976
Closed -$24K
OCA
6169
DELISTED
Omnichannel Acquisition Corp.
OCA
$0 ﹤0.01%
33
-1,067
-97% -$10.5K
LCAPU
6170
DELISTED
Lionheart Acquisition Corp. II Unit
LCAPU
$0 ﹤0.01%
+1
New +$10
AFI
6171
DELISTED
Armstrong Flooring, Inc.
AFI
– –
-12,758
Closed -$63K
LEJU
6172
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
– –
-66
Closed -$2K
ESBK
6173
DELISTED
Elmira Savings Bank Elmira NY
ESBK
– –
-89
Closed -$1K
GWGH
6174
DELISTED
GWG Holdings, Inc
GWGH
– –
-2,260
Closed -$16K
ALACW
6175
DELISTED
Alberton Acquisition Corp Warrant
ALACW
$0 ﹤0.01%
+175
New +$66
245 246
247
248 249

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.